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Abstract.  In an earlier report (Volloch,  V.,  1986, 
Proc. Natl. Acad. Sci. USA.,  83:1208-1212) we had 
presented evidence for the occurrence of the cytoplas- 
mic synthesis of globin mRNA and of RNA com- 
plementary to globin mRNA which differed from 
DNA-dependent transcription by its insensitivity to ac- 
tinomycin D.  In this paper, we describe the use of 
enucleated differentiating mouse erythroleukemia cells 
to demonstrate directly the occurrence of cytoplasmic 
synthesis of both positive- and negative-strand globin 
RNA. For this purpose,  we developed an enucleation 
procedure which yielded pure cytoplasts from differen- 
tiated mouse erythroleukemia cells in the absence of 
cytochalasin B and selectively permeabilized the 
cytoplasts to small molecules by treatment with dex- 
tran sulfate and saponin. The permeabilized cytoplasts 
incorporated [3H]dUTP  into positive- and negative- 
strand globin RNA and experiments with mercurated 
nucleotide substrate  suggested  that this process in- 
volved de novo RNA synthesis rather than limited ter- 
minal nucleotide addition. Globin RNA synthesis re- 
quired Mg  +÷, was inhibited by Mn  ÷+, and was 
unaffected by the addition of Zn  +÷.  Studies of its re- 
sponse to inhibitors of DNA-dependent RNA synthesis 
showed that it differed from that process in its insensi- 
tivity to actinomycin D and a-amanitin, but that like 
many other macromolecular biosynthetic reactions it 
was inhibited by rifamycin AF/ABDP and aurintricar- 
boxylic acid. These observations provide additional 
evidence for the occurrence of cytoplasmic RNA- 
dependent RNA synthesis in differentiated ceils and 
show permeabilized enucleated cells to be a useful ex- 
perimental system for further studies of the character- 
istics of that process. 
M 
URINE hematopoietic precursor cells can be trans- 
formed  by  Friend  virus  to  yield erythroid  cell 
lines, murine erythroleukemia (MEL)  j cells, which 
are blocked at a relatively advanced stage in their differentia- 
tion pathway (18). This block in erythroid differentiation is 
phenotypically reversible in vitro. When cultured in the pres- 
ence of an inducer  such as hexamethylenebisacetamide or 
DMSO, these cells become committed to a terminal differen- 
tiation program (13) and undergo a number of  changes which 
culminate in the loss of the nucleus (31, 32) and include loss 
of the capacity  for cell division  (10), accumulation  of the 
heme synthetic enzymes (33), alterations in membrane pro- 
teins composition (22), and most characteristically, massive 
synthesis and accumulation of globin mRNA and hemoglo- 
bin. A major factor responsible for the increase in hemoglo- 
bin synthesis may be the increase in the rate of transcription 
of  the corresponding globin gene (25). However, the involve- 
ment of a second mechanism is suggested by the recent re- 
port (30) that RNA-dependent RNA synthesis occurs in the 
cytoplasm of MEL cells using globin mRNA as a template 
and markedly increases during induction.  This mechanism 
is differentiation specific and may be an important  deter- 
1. Abbreviation  used in this paper:  MEL, murine erythroleukemia. 
minant of globin mRNA levels, as indicated by observations 
regarding the kinetics of globin RNA synthesis, localization 
of newly synthesized globin RNA, its size and distribution 
among different RNA fractions, distribution of radioactive 
nucleotides along the globin RNA molecule, drug sensitivity 
of synthesis, and presence of negative-strand globin RNA. 
Nevertheless, many questions remain unanswered and addi- 
tional evidence must be sought. Accordingly, we resorted to 
the use of enucleated cells or cytoplasts, which allows the 
separation of nuclear and cytoplasmic processes and avoids 
the need to use drugs such as actinomycin D, which may give 
rise to artifacts. A further refinement of this approach  in- 
volved selective permeabilization of  enucleated cells to allow 
manipulation  by the introduction  of molecules  of interest 
such as nucleotide substrates and inhibitors. As described in 
this paper, the use of  enucleated cells and their permeabiliza- 
tion allowed more detailed characterization of cytoplasmic 
RNA-dependent synthesis of globin mRNA. 
Materials and Methods 
Cell Culture 
MEL cells (line 745, clone PC4-12-9) were cultured in DME with. 15 % FCS 
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of hexamethylenebisacetamide  (4 mM; Aldrich Chemical Co., Milwaukee, 
WI) in 3% BSA or 2% FicoU 400. 
Preparation of  Enucleated Cells (Cytoplasts) 
Cytoplasts of differentiating MEL cells were prepared as described else- 
where (34), except that no cytochalasin B was used in the enucleation proce- 
dures.  A  discontinuous density gradient was prepared in ultracentrifuge 
tubes from solutions of Ficoll 400 (Pharmacia Fine Chemicals, Piscataway, 
NJ) in MEM (Gibco, Grand Island, NY). The FicoU stock solution (50% 
wt/wt in water, autoclaved and stored at  -20°C) was first diluUxt with an 
equal volume of double-strength MEM and then with MEM to the desired 
concentrations. The appropriate solutions were incubated in a CO2 incuba- 
tor, to a pH of 7.2-7.6, and then dispensed to yield a discontinuous gradient 
consisting of 25, 19, 18, 17, 16, 15, 12.5, and 10% Ficoll in MEM. The gra- 
dients were incubated for 12-18 h at 37°C before use, and then overlaid with 
cells in 10% Ficoll, followed by 2% Ficoil. After centrifngation at 25,000 
rpm for 60 min at 30°C, cytoplasts were collected from the appropriate 
banding interface (16-17 % Ficoll) with a syringe, diluted into fresh medium, 
pelleted by low speed centrifugation, resuspended in fresh medium, and 
diluted to the desired concentration for further studies. For preparation of 
the cytoplasts from uninduced MEL cells or from L cells, cytochalasin B 
was added to all fractions of  the gradient to a final concentration of 10 Ixg/ml 
(from stock solution of 2 mg/ml in DMSO). The efficiency of enucleation 
was determined by staining with Feulgen (DNA-specific) stain and found to 
be greater than 99.9%. 
Permeabilization of  Cytoplasts of  Differentiating 
MEL Cells 
All cell manipulations were carried out at 4°C. Cytoplasts were collected 
by centrifngation and resuspended in a buffer containing 50 mM Hepes, pH 
7.6,  80  mM  NaC1,  20  mM KCI,  1(3  mM MgCI2,  2  mM dithiothreitol 
(DTT), and 2 % Ficoll (Buffer A) and washed twice by centrifugation and 
resuspension in that buffer.  The suspension was adjusted to 10  g cytoplasts 
per ml and supplemented with an equal volume of dextran sulfate (200 
~tg/ml) plus saponin (200 Ixg/rnl) in Buffer A. Permeabilization was moni- 
tored by the uptake of the vital dye erythrosin B. A small sample of suspen- 
sion was incubated with erythrosin B (100 Ixg/ml) in Buffer A at 37°C for 
5  rain,  and  the  percentage  of  stained  cytoplasts  was  estimated  in  a 
hemacytometer. After 20 rain of permeabilization, more than 90% of the 
cytoplasts were stained. The hemoglobin content was determined as de- 
scribed elsewhere (17). 
Labeling and Preparation of  RNA 
Cytoplasts were resuspended in fresh medium containing 2% Ficoll (2-5 
×  l0  T cells per nil),  supplemented with  [5,6-3H]uridine  (60  Ci/mmol, 
Amersham Corp,  Arlington Heights, IL) to 2  mCi/ml, and incubated at 
37°C for appropriate time. Where indicated, actinomycin D (20 Ixg/ml) was 
added 5 rain before addition of radioactivity. 
Permeabilized cytoplasts were labeled with [3Hluridine in a buffer con- 
taming 50 mM Hepes, pH 7.6, 80 mM NaC1, 20 mM KCI, I0 mM MgCI2, 
2 mM DTT, 2 % Ficoll, 5 mM potassium phosphate, pH 7.6, 2.5 mM ATE 
0.2 mM CTP and GI'P, 0.01 mM [3H]UTP,  5 ~tg/ml polyvinylsulfate, and 
100 Ixg/ml saponin at 30°C for 30 rain. Labeling with [5-Hg]cytidine was 
done in a similar mixture containing 0.05 mM [5-HglCTP and 0.25  mM 
CTP. 
Labeled cytoplasts or permeabilized cytoplasts were collected by cen- 
trifugation and lysed by addition of a buffer containing 5 mM NaCI, 3 mM 
MgCI2,  30 mM Hepes, pH 7.8, and  1%  Triton X-100. The lysates were 
repeatedly extracted with penol and chloroform-isoamyl alcohol until the 
interphase was dear, and the resulting RNA was precipitated with ethanol. 
Assay of  Protein Synthesis 
Permeabilized cytoplasts were collected by centrifugation and incubated at 
final concentration of 2  x  107 cytoplasts per ml in buffer containing 100 
mM KOAc, 5 mM MgOAc, 50 mM tricine, pH 7.4, 20 ~tM L-[3I-I]leucine, 
0.2 mM of the other 19 amino acids, 0.1 mM GTE 1 mM ATE 5 mM phos- 
phoenolpyruvate, 0.2 unit pyruvate kinase, and 2 mM 2-mereaptoethanol at 
30°C.  At  appropriate  times of incubation,  samples were  removed and 
processed by trichloroacetic  acid (TCA) precipitation as described else- 
where (20). 
Fractionation of  RNA 
For size fractionation, RNA samples were suspended in 1130 Ixl of 85% for- 
mamide containing 113 mM Tris, pH 7.6, and 1 mM EDTA and heated at 
65°C for 5 rain before loading on the top of a 2-10% sucrose gradient in 
85 % formamide, 10 mM Tris, pH 7.6, and 1 mM EDTA. The gradient was 
centrifuged at 49,000  rpm in a SWS0.1 rotor (Beckman Instruments, Inc., 
Palo Alto, CA) for 14 h at 20°C. 
Separation of  RNA containing mereurated cytidine involved affinity chro- 
matography on thiol-agarose (Affigel 401,  Bio-Rad  Laboratories,  Rich- 
mond, CA) as described elsewhere (2). RNA was denatured by incubation 
at 70°C in 10 mM Tris, pH 7.4,  1 mM EDTA before application to thiol- 
agarose and the bound fraction was eluted with a buffer containing 2-mer- 
captoethanol and 10 I.tg/ml tRNA as a carrier. Less than 2 % of RNA sample 
was bound to and eluted from thiol-agarose. 
Hybridization of  RNA with Globin DNA-CeUulose 
RNA was hybridized to an excess of single-stranded recombinant M13 DNA 
containing the PstI-Pstl fragment of mouse [3 maj globin gene in either of 
two orientations and covalently bound to cellulose (23). Each mixture con- 
tained an equivalent of at least 30 ~g DNA and was incubated under the 
hybridization conditions described earlier (30).  To  ensure an excess of 
globin DNA cellulose, we determined a concentration curve for each prepa- 
ration of globin DNA-ceUulose with in vivo-labeled 3H RNA as described 
elsewhere (1). To  ensure  that  DNA  was  in  excess, equal  amounts  of 
DNA-ccllulose were hybridized with double amounts of labeled RNA in 
control hybridization. 
All results were corrected for the background that was determined for 
each experiment by hybridizing equal amounts of radioactive RNA no non- 
recombinant M13 DNA-cellulose and was 0.01% of RNA input or less. 
Results 
Preparation of  Cytoplasts of  Differentiated 
MEL Cells in the Absence of Cytochalasin B 
Enucleation of cells in suspension is usually achieved by 
treatment with cytochalasin B (10 lxg/ml) followed by isopyc- 
nic centrifugation in a discontinuous Ficoll gradient. As a re- 
sult of the disruption of the cytoskeleton by cytochalasin B, 
the centrifugal force leads to the extrusion of the denser 
nuclei from the cell, yielding the less dense cytoplast frac- 
tion, i.e., enucleated cells, and the denser karyoplasts, nuclei 
surrounded by plasma membrane. In the course of our study 
we discovered, however, that differentiating MEL cells could 
be enucleated in the absence of cytochalasin B and that this 
susceptibility to enucleation in a density gradient is a func- 
tion of differentiation. When mixed populations of differen- 
tiating and uninduced cells were subjected to density gra- 
dient centrifugation without treatment with cytochalasin B, 
undifferentiated cells remain intact and banded midway be- 
tween cytoplasts and karyoplasts derived from differentiated 
cells. The integrity of cytoplasts of differentiating MEL cells 
obtained by such a procedure, as judged by morphology and 
rate of protein synthesis, was significantly greater than that 
of cytoplasts obtained with cytochalasin B (data not shown). 
The cytoplasts obtained in this way originated exclusively 
from differentiating cells and contained less than 0.1% of in- 
tact cells and karyoplasts as judged by Giemsa and Feulgen 
staining. 
Synthesis of  Positive and Negative Strands of  Globin 
RNA in Cytoplasts of  Differentiating MEL Cells 
Cytoplasts were collected as the upper band in a Ficoll gra- 
dient  as  described  above  and  were  labeled  for  different 
periods  with [3H]uridine,  lysed, and subjected to phenol 
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Radioactivity  in  Radioactivity  in 
Labeling  Actinomycin D  positive-strand  negative-strand 
Origin of enucleated  cells  period  added  globin RNA  globin RNA 
min  lt  g /ml  cpm  cpm 
Differentiated MEL cells  15  0  261  112 
Differentiated MEL cells  30  0  611  184 
Differentiated MEL cells  30  20  563  167 
Differentiated MEL cells*  30  0  412  141 
Differentiated MEL cells  45  0  817  194 
Differentiated MEL cells  60  0  931  181 
Differentiated MEL cells  60  20  943  183 
Undifferentiated MEL cells  30  0  34  0 
Undifferentiated MEL cells  60  0  39  0 
L  cells  30  0  0  0 
L  cells  60  0  0  0 
Enucleated cells (1  x  108) were labeled with [~H]uridine as indicated.  RNA was isolated and hybridized to an excess of single-stranded  M13 DNA containing 
13 maj globin DNA in the appropriate  orientation and the amount of radioactive  RNA hybridized was determined as described in the text. 
* Labeled RNA was hybridized with PstI-XbaI fragment of globin DNA in the appropriate  orientation.  (PstI-PstI fragment corresponds to 367 Y-end nucleotides, 
PstI-Xbal fragment corresponds to 259 Y-end nucleotides.) 
chloroform extraction. Isolated RNA was hybridized with 
two preparations of immobilized single-stranded M13 DNA 
containing globin DNA  in the two possible orientations. 
RNA isolated from cytoplasts of L  cells or of uninduced 
MEL cells, obtained using cytochalasin B, served as con- 
trois. As shown in Table I, the synthesis of  both positive- and 
negative-globin RNA strands was observed in cytoplasts of 
differentiating MEL cells and was only slightly inhibited by 
actinomycin D. Whereas labeled globin mRNA accumulated 
continuously during labeling, the level of labeled RNA cor- 
responding to the globin-negative strand reached a plateau 
within 30 min, suggesting that it is subject to a rapid turn- 
over.  It is unlikely that the appearance of negative-strand 
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Figure 1. Sedimentation behavior of globin RNA labeled in cyto- 
plasts of differentiated  MEL cells. Cells were treated for 4 d with 
4 mM hexamethylenebisacetamide  and enucleated as described. 2 
x  l0  s cytoplasts were labeled for 60 rain with [~H]uridine, total 
RNA was isolated, dissolved in 85% formamide containing 10 mM 
Tris, pH 7.6, and 1 mM EDTA, denatured by heating at 650C and 
fractionated on sucrose-formamide gradient. Each of the gradient 
fractions was hybridized to an excess of single-stranded globin 
DNA in M13 covalently  bound to cellulose. (,4) Hybridization ma- 
trix contains single-stranded DNA complementary to the positive- 
strand globin RNA.  (B)  Hybridization matrix contains single- 
stranded DNA complementary to the negative-strand  globin RNA. 
RNA was an artifact due to hybridization of labeled positive- 
strand to contaminating double-stranded recombinant M13 
DNA,  since DNA  was immobilized under nondenaturing 
conditions where double-stranded DNA binds minimally. 
Moreover, double-stranded DNA, even if bound, would not 
effectively  hybridize with labeled RNA under the conditions 
used. To confirm this conclusion, globin cDNA was cloned 
in pGEM (Promega Biotec, Madison, WI) vector contain- 
ing SP6  and T7  promoters  and radioactive positive- and 
negative-globin mRNA strands were synthesized from lin- 
earized DNA using appropriate RNA polymerases. These 
RNA preparations were hybridized with hybridization ma- 
trix  containing  single-stranded  DNA  complementary  to 
positive or negative strands of globin RNA. Both hybridiza- 
tion matrixes  hybridized exclusively with an  appropriate 
RNA preparation. To test the possibility of cellular DNA in- 
terference with our measuring procedure, the identical ex- 
periments were carded out using RNA preparations pre- 
treated  with  DNase  A  (Worthington Biochemical Corp., 
Freehold, NJ,  RNase-free, 20 rain, 20°C in  10 mM Tris, 
pH 7.5, 10 mg MgC12). The results were essentially the same 
as shown in Table I, ruling out this possibility. 
Both  labeled  positive  and  negative  strands  of globin 
mRNA migrated as 9S RNA in formamide-sucrose gradient 
(Fig.  1). 
Preparation and Characterization  of  Permeabilized 
Cytoplasts of  Differentiating MEL Cells 
Permeabilization of cytoplasts was achieved by treatment 
with saponin (24)  and dextran sulfate (16). The following 
criteria were used to evaluate the procedure: (a) permeability 
to small molecules; (b) cellular integrity; and (c) ability to 
support synthesis of globin mRNA. Uptake of the vital dye 
erythrosin B, which is negatively charged and cannot cross 
the intact plasma membrane, was used as a measure of per- 
meabilization. Another criterion of  cell permeability was the 
partial release of hemoglobin after treatment. The ability to 
support synthesis of proteins as measured by incorporation 
of radioactive amino acids was used as an indication of cellu- 
lar  integrity.  The  ability  to  support  synthesis  of globin 
mRNA was evaluated by labeling permeabilized cytoplasts 
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hybridization to immobilized recombinant M13 DNA. Treat- 
ment with a combination of dextran sulfate and saponin gave 
satisfactory  permeabilization  according  to  these  criteria, 
leading to erythrosin B  staining of more than 90%  of the 
cytoplasts and the release of 30 % of cellular hemoglobin, 
while the incorporation of tritiated leucine into protein was 
linear for 45 min and that of radioactive UTP into globin 
mRNA for at least 30 min. 
Radioactivity Is Incorporated Only into 
Newly Synthesized Globin mRNA Molecules 
A possible explanation for the observed cytoplasmic labeling 
of globin mRNA is the modification of preexisting globin 
RNA. The possibility of terminal addition of nucleotides to 
preexisting globin mRNA was addressed previously by using 
the cloned MboII-HindIII fragment of the [3 maj globin gene 
which contains the second of the three globin gene exons, as 
hybridization template, followed by treatment with RNase A 
(30). The observed hybridization with the internal exon indi- 
cated that cytoplasmic labeling of globin RNA was not sim- 
ply due to end addition.  The availability of permeabilized 
cytoplasts made possible another approach to the question of 
de novo synthesis of globin mRNA.  This involved double 
labeling with [3H]UTP and [5-Hg]CTP and took advantage 
of the fact that nucleic acids containing mercurated nucleo- 
tides bind specifically to thiol-substituted agarose. This bind- 
ing requires about one mercury derivative in 100-200 nu- 
cleotides (2, 7) or •3-6  Hg for a molecule the size of 9S 
globin mRNA.  Under our experimental conditions, which 
involved the use of CTP and [5-Hg]CTP in a 5:1 molar ratio, 
the incorporation of at least  18-36 cytidylate residues or 
~70-140 nucleotides would thus be necessary for the binding 
of globin mRNA to thiol-agarose. The determination of the 
relative  degrees  of  [3H]UMP  incorporation  into  globin 
mRNA fractions bound or unbound by thiol-agarose would 
therefore provide an indication whether the 3H-labeled mol- 
ecules were the products of limited or extensive synthesis. 
The results of such an experiment are shown in Table II and 
indicate that radioactivity was exclusively incorporated into 
the globin mRNA fraction that bound to thiol-agarose, al- 
though that fraction presumably represents only a very small 
proportion of the total globin mRNA. It appears, therefore, 
that cytoplasmic labeling of globin mRNA represents rela- 
tively extensive, i.e., de novo, synthesis and not the addition 
Table II. Incorporation of [5-Hg]CTP and [~H]UTP 
into Positive and Negative Strand Globin RNA 
in Permeabilized Cytoplasts of  Differentiated MEL Cells 
Radioactivity  in  Radioactivity  in 
positive-strand  negative-strand 
Fraction of RNA  globin RNA  globin RNA 
cpm  cpm 
Bound to thiol-agarose  932  185 
Not bound to thiol-agarose  51  16 
Enucleated cells (3  x  10  s) were permeabilized and labeled with [5-Hg]CTP 
and [3H]UTP for 30 min, RNA was isolated, separated on thiol-agarose into 
a mercurated (bound) and an unmercurated (unbound) fraction, and hybridized 
to an excess of single-stranded M13 DNA containing 13 maj globin DNA in ap- 
propriate orientation, and the amount of radioactivity hybridized in each frac- 
tion was determined.  (For details,  see text.) 
of just a few nucleotide residues at the ends of the globin 
mRNA molecules. 
It was suggested by one of the reviewers that these results 
are also consistent with the possibility that small fragments 
of both plus and minus sense of globin RNA (which may be 
generated by natural degradation of globin RNA or by its 
degradation during preparation of permeabilized cytoplasts) 
may be used as primers on appropriate template RNA for 
synthesis of new RNA products. If this is the case, one may 
expect that position of initiation and thus the 5' end of newly 
synthesized RNA will be determined by the priming frag- 
ment. On the other hand, the 3' end of the newly synthesized 
RNA will correspond to the 5' end of the template. To exam- 
ine this possibility, labeled RNA was hybridized with an ex- 
cess of single-stranded recombinant M13  DNA containing 
only the 3' part (PstI-XbaI fragment) of the globin gene in 
either of the two orientations and covalently bound to cellu- 
lose (30). With random initiation and constant termination 
site,  one would expect that more newly synthesized RNA 
will hybridize with the 5' end fragment of the gene than the 
3' end fragment (at least for minus sense RNA).  However 
(Table I) proportionally equal amounts of newly synthesized 
RNA hybridize with both end fragments.  Although these 
results do not exclude the possibility that 3' end fragments 
are preferentially used to prime the synthesis of complemen- 
tary RNA strand, taken together with the results presented 
in Fig.  1 they strongly suggest synthesis of a full-size RNA 
copy. 
The permeabilized cytoplast system also allowed us to ad- 
dress  in more detail the possibility of DNA involvement. 
One may assume that permeabilized cells or permeabilized 
cytoplasts depend entirely on added nucleotide triphosphates 
(NTPs) or deoxynucleotide triphosphates (dNTPs) for RNA 
or DNA synthesis. This is definitely true in our case-if only 
one labeled NTP is added to permeabilized cells or cyto- 
plasts or if only one labeled dNTP is added to permeabilized 
cells, no incorporation is observed. Since no dNTPs were 
added to enucleated cytoplasts, we assume that no DNA syn- 
thesis is involved in the observed phenomenon. Moreover, 
the addition of 2  mM ddATP in our experiment does not 
change its outcome. 
Divalent Cation Requirements for Synthesis 
of Globin RNA in Permeabilized Cytoplasts 
The availability of permeabilized cytoplasts also allowed us 
to compare certain properties of cytoplasmic RNA synthesis 
with those of known nucleic acid polymerases. It was shown 
previously that Mg  ÷÷ is essential for the activity of RNA- 
dependent RNA polymerases in viral/eukaryotic systems and 
cannot be replaced by Mn  ++, which strongly inhibits the en- 
zyme activity (11, 21). The optimum Mg  ÷÷ concentration for 
the picornaviral RNA replicases was very narrow (8). The 
rate of cytoplasmic globin RNA synthesis showed little varia- 
tion with Mg  ÷÷ in the 5-20 mM range (data not shown). 
However in the absence of Mg  ÷÷, both positive- and nega- 
tive-strand synthesis of globin RNA was reduced almost 10- 
fold (Table III). Replacement of Mg  ÷÷ with Mn  +÷ restored 
the activity to only 25 % of the control level, and Mn  ÷÷ in- 
hibited the activity in the presence of Mg  +÷. Another diva- 
lent cation, Zn  ÷÷, essential for all DNA and RNA polymer- 
ases  examined  (3,  19),  can  replace  Mg  +÷  with  DNA 
polymerases from various organisms  (27).  In our system, 
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of  Differentiated MEL Cells 
[3H]UMP incorporated  into  [3H]UMP incorporated  into 
Divalent cations added  positive-strand  globin RNA  negative-strand  globin RNA 
cpm  cpm 
None  124  28 
10  mM MgCI2  1071  198 
1 mM MnC12  187  54 
10  mM  MnC12  272  61 
10  mM MgCI2,  10  mM  MnCI2  294  78 
Enucleated cells (3  ×  10  s) from 4-d-induced  MEL cells were permeabilized and labeled with [3H]UTP for 30 min in a mixture containing the indicated levels 
of divalent cations. RNA was isolated, hybridized with an excess of single-stranded M13 DNA containing IB maj globin DNA in appropriate orientation,  and the 
amount of radioactivity hybridized was determined. 
however, the addition of zinc in a wide range of concentra- 
tions (10-100 mM) had no significant effect on the synthesis 
of  globin  RNA,  nor  could  it  replace  Mg  ++  (data  not 
shown). 
Effect of lnhibitors of Nucleic Acid Synthesis 
The response of the RNA synthesizing activity in our system 
to certain inhibitors of nucleic acid synthesis was also exam- 
ined (Table IV).  In agreement with our previous observa- 
tions in whole cells (30) and intact cytoplasts (Table I) globin 
RNA synthesis was not inhibited by actinomycin D.  It also 
was  resistant to a-amanitin and to rifampicin, but was in- 
hibited, by the rifamycin derivative AF/ABDP and by aurin- 
tricarboxylic acid. 
Discussion 
Earlier experiments had suggested that globin mRNA syn- 
thesis could occur in the cytoplasm of differentiating MEL 
cells,  presumably by a  mechanism that involved RNA-de- 
pendent RNA synthesis and RNA complementary to globin 
mRNA Cnegative-strand" globin RNA) as an intermediate 
(30).  The evidence for this conclusion came in part from 
studies of the kinetics of globin RNA synthesis, its response 
to inhibitors,  and the localization of the product,  none of 
which alone constituted definitive proof for our hypothesis. 
To demonstrate  directly the  occurrence of cytoplasmic 
synthesis  of globin  mRNA,  we  turned  to  the  study  of 
enucleated cells. Our approach was based on the earlier ob- 
servation by Prescott et al.  (26) that cultured mammalian 
cells  could  be  readily  enucleated  after  treatment  with 
cytochalasin B by exposure to a centrifugal field. This proce- 
dure originally involved centrifugation of cells attached to a 
surface but was subsequently extended by Wigler and Wein- 
stein (34) to cells in suspension by the use of isopycnic cen- 
trifugation in a discontinuous density gradient of Ficoll 400 
containing  cytochalasin B.  Preparations  of cytoplasts and 
karyoplasts obtained in this manner have been used in vari- 
ous investigations, such as studies on the site of replication 
of a variety of viruses (15, 28, 29), the cellular responses to 
hormones and interferon (14, 36), and localization of various 
cellular functions (5, 6). Centrifugal field-induced enuclea- 
tion  could also be achieved with  MEL.  However, in the 
course of studying this process we made the very useful ob- 
servation that  differentiating  MEL  cells  were  enucleated 
upon isopycnic centrifugation even in the absence of cyto- 
chalasin B, perhaps due to a cytoskeleton alteration accom- 
panying the differentiation process. Cytoplasts produced in 
the absence of cytochalasin B were not only obtained with 
better yields, but showed a higher degree of functional in- 
tegrity as indicated by the rate of [3H]leucine incorporation 
into protein (our unpublished data). Another advantage ac- 
crued from the fact that only differentiating MEL cells were 
enucleated in the absence of cytochalasin B while undiffer- 
entiating cells remained intact and banded at a different posi- 
tion in the FicoU density gradient.  Accordingly, even with 
mixed cell populations, cytoplasts from differentiating cells 
could be obtained 99.9% pure from the uppermost band in 
the density gradient. 
Table IV. Effect of  lnhibitors on Positive and Negative Strand Globin RNA Synthesis in 
Permeabilized Cytoplasts of  Differentiated MEL Cells 
[3H]UMP incorporated  [3H]UMP incorporated 
into positive-strand  into negative-strand 
Inhibitor  added  globin RNA  Inhibition  globin RNA  Inhibition 
cpm  %  cpm  % 
None  1071  -  198  - 
Actincomycin D, 20 mg/rnl  952  11  204  0 
a-Amanitin, 20 Ixg/ml  912  14  167  15 
Rifampicin, 100 gg/ml  906  15  174  12 
Rifamycin AF/ABDP, 100 ~tg/ml  331  69  48  78 
Aurincricarboxylic acid, 5 IxM  217  79  22  82 
Enucleated cells (3  ×  10  a) from 4-d-induced  MEL cells were permeabilized and labeled with [3H]UTP for 30 min in the presence of inhibitors as indicated. RNA 
was isolated, hybridized with an excess of single-stranded M 13 DNA containing globin DNA in appropriate orientation, and the amount of radioactivity hybridized 
was determined. 
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ing MEL cells, completely free of contaminating nucleated 
cells, allowed us to establish definitively the occurrence of 
the  cytoplasmic synthesis  of both positive- and  negative- 
strand globin mRNA. Studies of the kinetics of this process 
indicated  that  the  accumulation of negative-strand globin 
RNA reached a maximum while positive-strand accumula- 
tion continued, consistent with the notion that the negative- 
strand RNA is a relatively unstable intermediate template in 
the RNA-dependent synthesis of globin mRNA. The rate of 
labeling of globin mRNA in cytoplasts was 30-50% of that 
seen earlier with whole differentiating MEL cells (30). 
To  characterize  further  the  properties  of cytoplasmic 
globin RNA synthesis, we subjected cytoplasts to selective 
permeabilization by treatment with saponin and dextran sul- 
fate. This allowed the study of the effect of substances that 
do not readily cross the plasma membrane, such as nucleo- 
tide substrates, metal ions, and various inhibitors. By using 
mercury-substituted CTP as substrate, it was possible to sep- 
arate  newly  synthesized  globin  RNA  from  bulk  globin 
mRNA by adsorption to thiol-agarose and show that the cyto- 
plasmic  incorporation of radioactive precursors into both 
positive- and negative-strand globin RNA involved substan- 
tial synthesis of RNA molecules rather than the terminal ad- 
dition of a few nucleotide residues to preexisting RNAs. It 
was also possible to examine the divalent cation requirement 
of cytoplasmic globin RNA synthesis and show that it de- 
pended on the presence of Mg  ÷÷, was inhibited by Mn  ÷+, 
and showed no response to Zn  ++.  These properties can be 
compared to those of viral RNA replicases, which are also 
Mg++-dependent and inhibited by Mn  ÷÷ but are stimulated 
by the addition of Zn  +÷ (3, 8). The lack of effect of Zn  ÷+ in 
our system could be due to the presence of saturating levels 
of this ion in the cytoplast preparations,  and  studies with 
specific chelators will be necessary to determine whether cy- 
toplasmic globin RNA synthesis is indeed Zn++-dependent 
as all other DNA and RNA polymerases described to date 
(3,  14, 27). 
We also tested the effect of several inhibitors of RNA syn- 
thesis on the synthesis of globin RNA in our assay system. 
We found it to be resistant to actinomycin D and a-amanitin, 
both potent inhibitors of DNA-dependent RNA synthesis, as 
well as to rifampicin, an inhibitor of  both bacterial and mito- 
chondrial DNA-dependent RNA polymerases. The possibil- 
ity that these inhibitors were not effective because they did 
not penetrate cytoplasts is unlikely in view of the fact that he- 
moglobin could pass through the plasma membrane of the 
permeabilized cytoplasts. Cytoplasmic globin RNA synthe- 
sis was inhibited by the rifamycin derivative AF/ABDP and 
by aurintricarboxylic acid. The former has been shown to in- 
hibit  a  number  of eukaryotic  DNA-dependent  DNA  and 
RNA polymerases as  well as RNA-dependent RNA poly- 
merase (9, 35) and thus appears to be a general inhibitor of 
both DNA and RNA synthesis. Aurintricarboxilic acid has 
been shown to inhibit RNA-dependent DNA polymerase, as 
well as RNA-dependent RNA polymerases (4, 12) by binding 
to the template binding site on the polymerase. The obtained 
results strongly suggest that at least de novo DNA synthesis 
is not involved in the observed phenomenon:  synthesis of 
RNA occurs in the permeabilized cytoplasts not only without 
addition of dNTPs but also when ddNTP is added. 
MEL cells are known to harbor the Friend virus complex, 
which consists of a replication-defective  murine leukemia vi- 
rus and a helper virus, spleen focus-forming virus. Replica- 
tion of these viruses occurs through a reverse transcription 
mechanism: viral RNA is used as a template by the virus- 
encoded  enzyme,  reverse  transcriptase,  to  produce  viral 
DNA. Since this mechanism operates in the cytoplasm, one 
may  speculate  that  it might  be  involved in  the  observed 
phenomenon of cytoplasmic synthesis of globin mRNA in 
differentiating  MEL  cells.  Several  arguments,  however, 
speak against this possibility. If reverse transcription were 
involved in the observed phenomenon, one would expect to 
find newly synthesized globin DNA. No such synthesis was 
observed in our experiments.  One could speculate that a 
short-lived or preexisting DNA, synthesized by reverse tran- 
scriptase, might act as a template for the cytoplasmic synthe- 
sis of globin RNA. However, in that case, globin RNA syn- 
thesis,  like all DNA-dependent RNA synthesis, should be 
sensitive to actinomycin D,  contrary to our observations. 
Moreover, this mechanism could not account for the appear- 
ance of negative-strand globin RNA,  which is specifically 
predicted by our model of RNA-dependent RNA synthesis. 
The detection of negative-strand globin RNA is a key discov- 
ery which strongly suggests that it and not a cDNA is an in- 
termediate  in  the  cytoplasmic  synthesis  of globin  RNA. 
Finally,  RNA-dependent RNA  synthesis  increases greatly 
during differentiation of MEL cells under conditions when 
reverse transcriptase  activity rapidly  declines,  suggesting 
that these activities are unrelated. 
The  question  remains,  however,  whether  the  observed 
mechanism indeed plays a physiological role in normal cells. 
Our  recent  results  answer  affirmatively to  this  question. 
Using  spleen  cells  of anemic  mice  (number  of different 
strands),  we were able to reproduce all our findings with 
MEL cells.  Moreover, we demonstrated that globin RNA 
synthesis also occurs in mature mouse reticulocytes (Vol- 
loch, V.,  B.  Schweitzer, and S.  Rits, manuscript in prepa- 
ration). 
The results of this study, combined with the results re- 
ported previously (30) provide strong  support for our hy- 
pothesis that RNA-dependent RNA synthesis occurs in the 
cytoplasm of differentiating MEL cells. The mechanism and 
features of this synthesis as well as its biological significance 
and range of application are the subject of our current and 
future investigations, which take advantage of permeabilized 
enucleated cells as a convenient in vitro assay system. 
The authors are indebted to Dr. Henry Paulus for his inspirational support, 
helpful suggestions, and careful reading of this manuscript, and to Mrs. 
Dotty Syrigos for typing this manuscript. 
This work was supported by grants R01-CA33953 from the National Insti- 
tutes of Health and 5-481  from the March of Dimes. 
Received for publication 22 December 1986, and in revised form 27 March 
1987. 
References 
I. Adman, R., L. D. Shultz, and B. D. Hall.  1972.  Transcription in yeast: 
separation and properties of multiple FNA. Proc, Natl. Acad. Sci.  USA. 
69:1702-1706. 
2. Banfalvi, G., S. Bhattacharya, and N. Sarkar.  1985. Selective  isolation of 
mercurated DNA by affinity chromatography on thiol matrices. Anal. 
Biochem.  146:64-70. 
3. Baron, M., and D. Baltimore. 1982. In vitro copying of viral positive strand 
RNA by poliovirns replicase. J.  Biol.  Chem.  257:12359-12366. 
4. Blumentahl, T., and T. A. Landers.  1973.  The inhibition of nucleic acid 
binding proteins  by  aurintricarboxylic acid.  Biochem.  Biophys.  Res. 
The Journal of Cell Biology, Volume 105,  1987  142 Commun. 55:680-688. 
5. Croce, C., and H. Kaprowsky.  1973. Enucleation of cells made simple and 
a rescue of SV-40 by enucleated cells made even simpler.  Virology. 51 : 
227-235. 
6. Croce,  C. M., G. Litwack, and N. Koprowsky.  1973. Human regulatory 
gene for inducible tyrosine aminotransferase in rat-human hybrids. Proc. 
Natl.  Acad. Sci. USA. 70:1268-1272. 
7. Dale, R., and D. C. Ward.  1975. Mercurated polynucleotides: new probes 
for hybridization and selective polymer fractionation. Biochemistry.  14: 
2458-2469. 
8.  Dasgupta, A., M. Baron, and D. Baltimore.  1979. Poliovirus replicase. A 
soluble enzyme able to initiate copying of poliovirus RNA. Proc. Natl. 
Acad.  Sci. USA. 76:2679-2683. 
9.  Downey, R., J. J. Byrnes, B. S. Jurmark, and A. G. So. 1973. Reticulocyte 
RNA-dependent  RNA  polymerase.  Proc.  Natl. Acad. Sci. USA. 70: 
3400-3404. 
10.  Fibach,  E., R. C. Reuben, R. A. Ritkind,  and P. A. Marks.  1977. Effect 
of hexamethylenebisacetamide  on the commitment to differentiation of 
murine erythroleukemia  cells.  Cancer Res.  37:440-444. 
11.  Flanegan,  J., and D. Baltimore.  1977. Poliovirus-specific primer-depen- 
dent RNA polymerase able to copy poly(A). Proc. NatL Acad. Sci. USA. 
74:3677-3680. 
12. Givens, J. F., and R. F.  Manly.  1976. Inhibition of RNA-directed DNA 
polymerase by aurintricarboxylic  acid. Nucleic Acids Res.  3:405--418. 
13.  Gusella, J., R. Geller, B. Clarke, V. Weeks, and D. Housman. 1976. Com- 
mitment to erythroid  differentiation by Friend  erythroleukemia  cells: a 
stochastic analysis.  Cell. 9:221-229. 
14. Irvine,  R., W. Fau, and G. Tomkins.  1975. Analysis of the induction and 
reinduction oftyrosine aminotransferase in enucleated HTC cells. J. Cell. 
Physiol.  85:357-368. 
15. Kos, K. A., B. A. Osborne, and R. A. Goldsby.  1975. Inhibition of group 
B arbovirus antigen production and replication in cells enucleated with 
cytochaiasin  B. J.  Virol. 15:913-919. 
16.  Kucera, R., and H.  Paulus.  1982. Studies on ribonucleoside-diphosphate 
reductase in permeable animal cells. Arch. Biochem. Biophys. 214:102- 
113. 
17.  Lieberman, D., V. Volloch, H. Aviv, and V. Revel. 1974. Effects of inter- 
feron on hemoglobin synthesis and leukemia virus production in Friend 
cells.  Mol. BioL Rep. 1:447-458. 
18.  Marks,  P. A., and R. A. Rifkind.  1978. Erythroleukemia differentiation. 
Annu.  Rev.  Biochem. 44:419-448. 
19.  Mildvan, A. S., and L. A. Loeb. 1979. The role of metal ions in the mecha- 
nisms of DNA and RNA polymerases.  CRC Crit. Rev. Biochem. 6:219- 
244. 
20.  Miller, M. R., J. J. Castellot, and A. B. Pardee. 1978. A permeable animal 
cell preparation for studying macromolecular synthesis.  DNA synthesis 
and the role of deoxyribonucleotides in S phase initiation. Biochemistry. 
17:1073-1080. 
21.  Morrow, C., J. Lusinsky, J. Hocko, G. Gibbons, and A. Dasgupta.  1985. 
Purification of a soluble template-dependent rhinovirus RNA polymerase 
and its dependence on a host cell protein for viral RNA synthesis. J.  Virol. 
53:22-29. 
22.  Muller, C., V. Volloch, and M. Shinitsky.  1980. Correlation between cell 
density, membrane fluidity and the availability of transferrin receptors in 
Friend erythroleukemic  cells.  Cell Biophys.  2:233-239. 
23.  Noyes,  B.,  and G.  Stark.  1975. Nucleic acid  hybridization  using  DNA 
covalently coupled to cellulose.  Cell. 5:301-310. 
24. Oda,  T., S. Watanabe,  Y. Maki,  H. lwamoto,  and S.  Hanakawa.  1984. 
DNA replication of simian virus 40 chromatin  in digitonin-treated  and 
saponin-treated permeable cells. Biochem.  Int. 9:763-769. 
25.  Pofous-Juchehia, H. R., R. C. Reuben, P. A. Marks,  and R. A. Rifkind. 
1983. Transcriptional and post-transcriptional  regulation of globin gene 
accumulation in murine erythroleukemia cells.  Mol. Cell. Biol. 3:229- 
232. 
26.  Prescott, D. M., D. Myerson, and J. Wallace.  1972. Enucleation of mam- 
malian cells with cytochalasin B. Exp. Cell Res.  71:480-486. 
27.  Sirover, M. A., and L. A. Loeb. 1976. Metal activation of DNA synthesis. 
Biochem. Biophys.  Res. Commun. 70:812-817. 
28.  Sokil, F. and H. Koprowsky.  1975. Structure-function  relationships and 
mode of replication of  animal rhabdoviruses. Proc. Natl. Acad. Sci. USA. 
72:933-937. 
29.  Varmus, M. E., R. V. Guntaka, W. Fan, S. Heasley, andJ. Bishop. 1974. 
Synthesis of viral DNA in the cytoplasm of duck embryo fibroblasts and 
in enucleated cells after  infection by avian sarcoma virus.  Proc. Natl. 
Acad.  Sci. USA. 71:3874-3878. 
30.  Volloch, V.  1986. Cytoplasmic synthesis of globin RNA in differentiated 
murine erythroleukemia cells: possible involvement of RNA<lependent 
RNA polymerase.  Proc.  Natl. Acad. Sci. USA. 83:1208-1212. 
31. Volloch, V., and D. Housman.  1981. Globin mRNA stability in terminally 
differentiated MEL cells: globin mRNA is as stable as rRNA throughout 
the differentiation program.  Cell. 23:509-514. 
32.  Volloch,  V., and D. Housman.  1982. Terminal differentiation of murine 
erythroleukemia  cells:  physical stabilization of end stage cells. J.  Cell 
Biol.  93:390-394. 
33.  Volloch, V., A. Tsiftosoglou, R. Levenson, J. Gusella, J. Kernen, A. Mit- 
zani, and D. Housman.  1980. Globin gene expression in differentiating 
murine erythroleukemia cells. In Erythropoesis and Differentiating Mu- 
rine Erythroleukemia  Cells.  G. Rossi, editor.  147-161. 
34. Wigler, M. H., and I. B. Weinstein. 1975. A preparative method for obtain- 
ing enucleated mammalian cells. Biochem. Biophys. Res. Commun. 63: 
669-674. 
35. Wu, A., R. C. Ting, and R. C. Gallo.  1973. RNA-directed DNA polymer- 
ase and virus-induced leukemia in mice. Proc. Natl. Acad. Sci. USA. 70: 
1298-1302. 
36. Young,  C.,  C.  Pringle,  and  E.  Follett.  1975. Action  of interferon  in 
enucleated cells. J.  Virol.  15:428--437. 
Volloch et al.  Cytoplasmic Synthesis of Globin RNA  143 